Sign In

Andy De Deene

Chief Development Officer

Andy De Deene, MD, MBA, is an accomplished strategic International Industry Executive with 25 years of experience in Biotechnology and Pharma, holding a license in Dermatology and Allergy.

Possessing a proven track record in drug development, he has successfully navigated drugs through the regulatory process, including IND/BLA submissions and global marketing authorizations.

Andy De Deene has held key roles encompassing Clinical Development, Strategic Planning, Portfolio Management, Regulatory Affairs, New Product Development, and Commercial Aspects.

His expertise extends to diverse therapeutic fields such as Ophthalmology, Stroke, Oncology, Dermatology, Infectiology, and Immunology, covering a range of entities including New Chemical Entities, Biologic Entities, and Medical Devices.

With a background in Alliance Management, Due Diligences, Change Management, Organizational Design, Coaching, and General Management, he is a goal-oriented problem solver with strong interpersonal skills.

Andy De Deene
Add to my network

Location

Antwerp Metropolitan Area